Dr Reddys CFO MV Narasimham Wins Top Pharma Award

HYDERABAD: Dr. Reddy’s Laboratories Ltd., a prominent global pharmaceutical company, has announced that its Chief Financial Officer (CFO), M. V. Narasimham, has been honored as the ‘Best CFO in Pharmaceuticals’ for 2026.

The prestigious accolade was presented at the 9th BW CFO World’s Best CFO & Finance Strategy Excellence Awards, an annual event hosted by Businessworld to celebrate outstanding financial leadership. The award recognizes Narasimham’s exceptional contributions to building a highly robust, agile global finance function while driving long-term corporate stability and growth.

A Legacy of Financial Leadership:
A Chartered Accountant by qualification, Narasimham has been a pillar of Dr. Reddy’s leadership team for over two decades, having joined the organization in 2000. Before stepping into his current role as CFO, he served as the Deputy CFO, where he successfully spearheaded global commercial business finance and cross-border taxation across diverse international geographies.

“I’m truly delighted to receive this award,” said M. V. Narasimham, commenting on the achievement. “It is a testament to the strength of our team and our shared commitment to excellence. At Dr. Reddy’s, we continue to strengthen our financial foundation while enabling strategic growth, innovation, and resilience in a dynamic global environment, all while staying aligned with our core purpose of serving patient needs.”

Celebrating Excellence in Finance:
The Annual BW CFO World Awards are highly regarded in the corporate sector, designed to spotlight financial pioneers who exhibit extraordinary strategic thinking, rigorous financial stewardship, and innovation across various industries.

Narasimham’s recognition underscores Dr. Reddy’s ongoing commitment to balancing fiscal discipline with aggressive global innovation, ensuring the pharmaceutical giant remains competitive on the world stage.